Guanidinium‐Stapled Helical Peptides for Targeting Protein‐Protein Interactions
Angewandte Chemie International Edition · 27.01.2025 · 64 (5)
DOI: 10.1002/anie.202416348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 13.01.2025. Verfasst von Camille Perdriau und 11 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR5248, IECB, 2 rue Robert Escarpit, F-33600, Pessac, France. Hauptthemen laut MEDLINE: Guanidine, Peptides, Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agence Nationale de la Recherche, Conseil Régional Aquitaine, Association Nationale de la Recherche et de la Technologie.
Abstract (Originalsprache)
Peptide stapling has emerged as a versatile approach in drug discovery to reinforce secondary structure elements especially α‐helices and improve properties of linear bioactive peptides. Inspired by the prevalence of arginine in protein‐protein and protein‐DNA interfaces, we investigated guanidinium‐stapling as a means to constrain helical peptides. Guanidinium stapling was readily achieved on solid support, utilizing two orthogonally protected lysine or unatural α‐amino acid residues with an amino function. This method allows for easy modulation of the nature and size of the staple as well as helix propensity. Evaluating a set of guanidinium‐stapled peptides for their interaction with different protein targets identified several binders with increased target affinity. X‐ray structure determination of four complexes revealed that all stapled peptides adopt a helical conformation upon protein binding. Notably, the disubstituted guanidinium generally exhibits a distinct cis / trans conformation and, in one instance, retains a conserved hydrogen bond with the protein surface. By identifying, for the first time, the guanidinium moiety as an effective helical peptide stapling group, this research significantly expands the repertoire of α‐helix stapling techniques for the creation of useful protein mimics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR5248, IECB, 2 rue Robert Escarpit, F-33600, Pessac, France.
- IMMUPHARMA BIOTECH SAS, 15 rue de Bruxelles, 75009, Paris, France.
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM, U1258/CNRS, UMR 7104/Univ. Strasbourg, 67404, Illkirch, France.
- Univ. Bordeaux, CNRS, INSERM, IECB, UAR3033, US001, F-33600, Pessac, France.
- Discovery Sciences, R&D, AstraZeneca, Cambridge, CB2 0AA, UK.
ORCID-Profile: Katharina Zimmeter, Claire Saragaglia, Brice Kauffmann, Gavin W Collie, Natacha Rochel, Gilles Guichard, Morgane Pasco
Förderung
- Agence Nationale de la Recherche
- Conseil Régional Aquitaine
- Association Nationale de la Recherche et de la Technologie
Zitieren
APA
Perdriau, C., Luton, A., Zimmeter, K., Neuville, M., Saragaglia, C., Peluso-Iltis, C., Osz, J., Kauffmann, B., Collie, G. W., Rochel, N., Guichard, G., & Pasco, M. (2025). Guanidinium‐Stapled Helical Peptides for Targeting Protein‐Protein Interactions. Angewandte Chemie International Edition, 64(5). https://doi.org/10.1002/anie.202416348
Vancouver
Perdriau C, Luton A, Zimmeter K, Neuville M, Saragaglia C, Peluso-Iltis C, et al. Guanidinium‐Stapled Helical Peptides for Targeting Protein‐Protein Interactions. Angewandte Chemie International Edition. 2025;64(5). doi:10.1002/anie.202416348
BibTeX
@article{Perdriau2025,
author = {Perdriau, Camille and Luton, Anaïs and Zimmeter, Katharina and Neuville, Maxime and Saragaglia, Claire and Peluso-Iltis, Carole and Osz, Judit and Kauffmann, Brice and Collie, Gavin W and Rochel, Natacha and Guichard, Gilles and Pasco, Morgane},
title = {Guanidinium‐Stapled Helical Peptides for Targeting Protein‐Protein Interactions},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {5},
doi = {10.1002/anie.202416348}
}
EUVIMED